AbbVie gets expanded FDA approval for Qulipta to treat chronic migraine
Qulipta is an oral calcitonin gene-related peptide (CGRP) receptor antagonist, previously approved in the US, as a preventive…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
18 Apr 23
Qulipta is an oral calcitonin gene-related peptide (CGRP) receptor antagonist, previously approved in the US, as a preventive…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
18 Apr 23
The new plants will expand the company’s manufacturing network for active pharmaceutical ingredients and support the growing demand…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
17 Apr 23
Prometheus is a clinical-stage biotechnology company engaged in the discovery, development, and marketing of novel therapeutic and companion…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
03 Apr 23
Polyplus provides upstream solutions for the manufacturing of advanced biologic and cell and gene therapy, with a legacy…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
27 Mar 23
Joenja is indicated for activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS), which is caused by gain of function…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
21 Mar 23
Designated as GS-6791, NX‑0479 is a bivalent degrader which is the first development candidate resulting from the previously…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
16 Mar 23
The company will use the funding to advance its portfolio which comprises three novel antibody treatments that are…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
14 Mar 23
The deal will add Provention Bio’s Tzield disease-modifying treatment for delay of Stage 3 type 1 diabetes to…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
10 Mar 23
In addition, the UPA and AHF are combining their efforts towards maximizing the Egyptian role in promoting the…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
10 Mar 23
The late-stage trial compared the lung cancer drug with placebo in the late-stage trial in 682 patients having…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates